AliveCor announced that it is attending the American Heart Association Scientific Sessions taking place at McCormick Place in Chicago, from November 15-19. There will be many opportunities to learn more about the AliveCor Heart Monitor at the conference, including:

In-booth presentations and product demonstrations: AliveCor will offer in-booth presentations and product demonstrations on the clinical capabilities of the AliveCor Heart Monitor and the AliveECG app.

Atrial Fibrillation (AF) Detector: Learn more about AliveCor’s new FDA-cleared automated analysis process (algorithm) that instantly detects if patients are experiencing AF through real-time electrocardiogram (ECG) recordings taken on the AliveCor Heart Monitor, so intervention can take place before potentially life-threatening conditions, like strokes, occur.

A study published in the June 2014 issue of Thrombosis and Haemostasis demonstrated feasibility and cost effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: Nicole Lowres et al. Thrombosis and Haemostasis 2014: 111/6 (June) pp. 1007-1199.

A study published in the May 2014 issue of Australian Family Physician reported findings on iPhone screening by practice nurses and receptionists for atrial fibrillation in general practice: the GP-SEARCH qualitative pilot study: Jessica Orchard et al. Australian Family Physician Volume 43, No.5, May 2014.

The AliveCor Heart Monitor’s medical grade ECG recordings can also be shared directly with a physician, or sent to a US board-certified cardiologist or a US-based cardiac technician through a cloud-based ECG analysis service provided by AliveCor.

In as little as 30 minutes users can receive expert reviews of their ECGs directly through the AliveECG app providing a more complete picture of their current heart health.